Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
The American Journal of Psychiatry
|
September 2, 2006
Predictors of relapse in a prospective study of fluoxetine treatment of major depression
Patrick J McGrath, Jonathan W Stewart, Frederic M Quitkin, et al.
Clinical EEG and Neuroscience
|
November 17, 2010
EEG hemispheric asymmetries during cognitive tasks in depressed patients with high versus low trait anxiety
Carlye B G Manna, Craig E Tenke, Nathan A Gates, et al.
The Journal of Clinical Psychiatry
|
August 21, 2012
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression
David J Hellerstein, Jonathan W Stewart, Patrick J McGrath, et al.
The American Journal of Psychiatry
|
November 2, 2002
Are there differences between women's and men's antidepressant responses?
Frederic M Quitkin, Jonathan W Stewart, Patrick J McGrath, et al.
The Journal of Clinical Psychiatry
|
March 4, 2011
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
James G Barbee, Thomas R Thompson, Nowal J Jamhour, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 17, 2008
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
Marianne Gorlyn, John G Keilp, Michael F Grunebaum, et al.
Comprehensive Psychiatry
|
December 4, 2014
Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction
David J Hellerstein, Greg Erickson, Jonathan W Stewart, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
July 3, 2009
Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
Huaiyu Yang, Sarah Chuzi, Lara Sinicropi-Yao, et al.
Bipolar Disorders
|
October 12, 2019
Deficits of white matter axial diffusivity in bipolar disorder relative to major depressive disorder: No relationship to cerebral perfusion or body mass index
Martin J Lan, Harry Rubin-Falcone, M Elizabeth Sublette, et al.
Journal of Clinical Psychopharmacology
|
February 25, 2011
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
Shawn M McClintock, Mustafa M Husain, Stephen R Wisniewski, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
The American Journal of Psychiatry
|
September 2, 2006
Predictors of relapse in a prospective study of fluoxetine treatment of major depression
Patrick J McGrath, Jonathan W Stewart, Frederic M Quitkin, et al.
Clinical EEG and Neuroscience
|
November 17, 2010
EEG hemispheric asymmetries during cognitive tasks in depressed patients with high versus low trait anxiety
Carlye B G Manna, Craig E Tenke, Nathan A Gates, et al.
The Journal of Clinical Psychiatry
|
August 21, 2012
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression
David J Hellerstein, Jonathan W Stewart, Patrick J McGrath, et al.
The American Journal of Psychiatry
|
November 2, 2002
Are there differences between women's and men's antidepressant responses?
Frederic M Quitkin, Jonathan W Stewart, Patrick J McGrath, et al.
The Journal of Clinical Psychiatry
|
March 4, 2011
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
James G Barbee, Thomas R Thompson, Nowal J Jamhour, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 17, 2008
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
Marianne Gorlyn, John G Keilp, Michael F Grunebaum, et al.
Comprehensive Psychiatry
|
December 4, 2014
Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction
David J Hellerstein, Greg Erickson, Jonathan W Stewart, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
July 3, 2009
Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
Huaiyu Yang, Sarah Chuzi, Lara Sinicropi-Yao, et al.
Bipolar Disorders
|
October 12, 2019
Deficits of white matter axial diffusivity in bipolar disorder relative to major depressive disorder: No relationship to cerebral perfusion or body mass index
Martin J Lan, Harry Rubin-Falcone, M Elizabeth Sublette, et al.
Journal of Clinical Psychopharmacology
|
February 25, 2011
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
Shawn M McClintock, Mustafa M Husain, Stephen R Wisniewski, et al.
Page
of 8